Debora Barton

Debora Barton is a highly accomplished professional with a strong background in medicine and business.

She pursued her MD at distinguished institutions such as Universidade Federal de S\u00e3o Paulo, Pontif\u00edcia Universidade Cat\u00f3lica de S\u00e3o Paulo, and The University of Texas M.D. Anderson Cancer Center, showcasing her dedication to healthcare.

Furthering her expertise, Debora undertook Executive Education at prestigious establishments including Columbia Business School and Columbia University.

Debora Barton's career spans across various reputable organizations, highlighting her versatile skill set and leadership capabilities.

Currently, she serves as the Chief Medical Officer at Carisma Therapeutics, showcasing her leadership and strategic acumen in the healthcare industry.

In her previous roles, Debora held key positions such as Senior Vice President, Clinical and Head of Safety at Iovance Biotherapeutics, Inc., where she demonstrated her proficiency in clinical operations and safety protocols.

Her extensive experience includes serving as VP, Global Head of Oncology, Global Head of Medical Affairs, and Head of Clinical Development at Advanced Accelerator Applications, illustrating her expertise in oncology and medical affairs.

Debora Barton's background features roles at renowned pharmaceutical companies like Celgene and Novartis, where she contributed significantly to clinical research and oncology development.

She has also been involved in various medical advisory roles and boards, including the Tigerlily Foundation and American Cancer Society, showcasing her commitment to community welfare and healthcare initiatives.

Debora Barton's impressive career trajectory and educational achievements underline her as a seasoned professional in the medical and business domains, with a strong focus on oncology and clinical research.